- Home
- LDTC vs PTHL Comparison
LDTC vs PTHL Comparison
Compare LDTC & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- PTHL
- Stock Information
- Founded
- LDTC 2007
- PTHL 1998
- Country
- LDTC Canada
- PTHL China
- Employees
- LDTC N/A
- PTHL N/A
- Industry
- LDTC Blank Checks
- PTHL
- Sector
- LDTC Finance
- PTHL
- Exchange
- LDTC Nasdaq
- PTHL Nasdaq
- Market Cap
- LDTC 37.5M
- PTHL 43.1M
- IPO Year
- LDTC N/A
- PTHL 2024
- Fundamental
- Price
- LDTC $0.52
- PTHL $2.30
- Analyst Decision
- LDTC Buy
- PTHL
- Analyst Count
- LDTC 2
- PTHL 0
- Target Price
- LDTC $3.00
- PTHL N/A
- AVG Volume (30 Days)
- LDTC 247.3K
- PTHL 72.0K
- Earning Date
- LDTC 02-12-2025
- PTHL 02-11-2025
- Dividend Yield
- LDTC N/A
- PTHL N/A
- EPS Growth
- LDTC N/A
- PTHL N/A
- EPS
- LDTC N/A
- PTHL N/A
- Revenue
- LDTC $331,997.00
- PTHL $572,291.00
- Revenue This Year
- LDTC $1,128.94
- PTHL N/A
- Revenue Next Year
- LDTC $169.93
- PTHL N/A
- P/E Ratio
- LDTC N/A
- PTHL N/A
- Revenue Growth
- LDTC 141.86
- PTHL 2.32
- 52 Week Low
- LDTC $0.22
- PTHL $1.32
- 52 Week High
- LDTC $4.04
- PTHL $6.45
- Technical
- Relative Strength Index (RSI)
- LDTC 34.72
- PTHL N/A
- Support Level
- LDTC $0.42
- PTHL N/A
- Resistance Level
- LDTC $0.61
- PTHL N/A
- Average True Range (ATR)
- LDTC 0.09
- PTHL 0.00
- MACD
- LDTC -0.01
- PTHL 0.00
- Stochastic Oscillator
- LDTC 23.15
- PTHL 0.00
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.